154 related articles for article (PubMed ID: 35574415)
1. Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population.
Ni S; Wang X; Chang J; Sun H; Weng W; Wang X; Tan C; Zhang M; Wang L; Huang Z; Huang D; Xu M; Sheng W
Front Oncol; 2022; 12():842787. PubMed ID: 35574415
[TBL] [Abstract][Full Text] [Related]
2. Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer.
Liu F; Ren C; Jin Y; Xi S; He C; Wang F; Wang Z; Xu RH; Wang F
Virchows Arch; 2020 Mar; 476(3):391-398. PubMed ID: 31720832
[TBL] [Abstract][Full Text] [Related]
3. HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria.
Sun Q; Li Q; Gao F; Wu H; Fu Y; Yang J; Fan X; Cui X; Pu X
J Cancer Res Clin Oncol; 2023 Feb; 149(2):579-592. PubMed ID: 36018511
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
5. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
[TBL] [Abstract][Full Text] [Related]
6.
Zhang X; Wu J; Wang L; Zhao H; Li H; Duan Y; Li Y; Xu P; Ran W; Xing X
PeerJ; 2020; 8():e8602. PubMed ID: 32095377
[TBL] [Abstract][Full Text] [Related]
7. HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.
Seo AN; Kwak Y; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
PLoS One; 2014; 9(5):e98528. PubMed ID: 24879338
[TBL] [Abstract][Full Text] [Related]
8. Significance of HER2 protein expression and
Wang XY; Zheng ZX; Sun Y; Bai YH; Shi YF; Zhou LX; Yao YF; Wu AW; Cao DF
World J Gastrointest Oncol; 2019 Apr; 11(4):335-347. PubMed ID: 31040898
[TBL] [Abstract][Full Text] [Related]
9. Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings.
Gheni N; Westenberg D
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S123-S128. PubMed ID: 32108644
[TBL] [Abstract][Full Text] [Related]
10. Putative Clinical Potential of
Boldrin E; Mazza M; Piano MA; Alfieri R; Montagner IM; Magni G; Scaini MC; Vassallo L; Rosato A; Pilati P; Scapinello A; Curtarello M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565309
[TBL] [Abstract][Full Text] [Related]
11. [Dual-color silver-enhanced in-situ hybridization for determination of HER2 gene amplification in gastric carcinoma].
Fan D; Li Y; Ran W; Yu W; Li H
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):4-7. PubMed ID: 24713241
[TBL] [Abstract][Full Text] [Related]
12. Association between Her2/neu status in colorectal carcinoma and clinicopathological features: a retrospective study using whole - tissue sections.
Kılıçarslan A; Dogan HT; Süngü N; Dogan M; Yalcin A; Dede DŞ
Pol J Pathol; 2018; 69(2):143-149. PubMed ID: 30351861
[TBL] [Abstract][Full Text] [Related]
13. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of
Yeh YM; Lee CH; Chen SH; Lee CT; Chen YL; Lin BW; Lin SC; Chan RH; Lee JC; Shen MR; Lin PC
Cancer Manag Res; 2019; 11():7867-7875. PubMed ID: 31692488
[TBL] [Abstract][Full Text] [Related]
15. [Dual-color silver-enhanced in-situ hybridization and fluorescence in-situ hybridization for determination of HER2 gene status in gastric carcinoma].
Long XY; Bu H; Wei B; Liu XY; Chen M; Chen J; Liu JP
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):300-3. PubMed ID: 21756822
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
17. HER2 Status in RAS and BRAF Wild-Type Metastatic Colorectal Cancer: A Portuguese Study.
Fraga T; de Sousa MJ; Magalhães J; Basto R; Paulo J; Bonito N; Magalhães JP; Figueiredo P; Sousa GM
Cureus; 2023 Jul; 15(7):e42536. PubMed ID: 37637599
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
[TBL] [Abstract][Full Text] [Related]
19. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
20. Significance of human epidermal growth factor receptor 2 expression in colorectal cancer.
Tu J; Yu Y; Liu W; Chen S
Exp Ther Med; 2015 Jan; 9(1):17-24. PubMed ID: 25452770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
